Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Increasing the Contrast of the Brain MR FLAIR Images Using Fuzzy Membership Functions and Structural Similarity Indices in Order to Segment MS Lesions.
Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.
Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients.
Activated Human CD4+CD45RO+ Memory T-Cells Indirectly Inhibit NLRP3 Inflammasome Activation through Downregulation of P2X7R Signalling.
Transverse myelitis with Brown-Sèquard syndrome after H1N1 immunization.
Vitamin D-binding Protein in Cerebrospinal Fluid is Associated with Multiple Sclerosis Progression.
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.
Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Corticosteroids for treating optic neuritis.
EBV-Associated Cancer and Autoimmunity: Searching for Therapies.
Supportive or detrimental roles of P2Y receptors in brain pathology?-The two faces of P2Y receptors in stroke and neurodegeneration detected in neural cell and in animal model studies.
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.
Interlukin-18 Is a Pivot Regulatory Factor on Matrix Metalloproteinase-13 Expression and Brain Astrocytic Migration.
Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE.
IL-27 Limits Central Nervous System Viral Clearance by Promoting IL-10 and Enhances Demyelination.
Recognising and diagnosing inflammatory brain disease.
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Neurogenic pulmonary edema in pediatric multiple sclerosis: patient report and summary of cases.
Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review.
The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice.
The Olig family affects central nervous system development and disease.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis.

Pages